Since 30 years, bioengineering allowed to reconstruct human tissues using normal human cells. Skin is one of the first organ to be reconstructed thanks to the development of specific cell culture media and supports favoring the culture of human skin cells, such as fibroblasts, keratinocytes, or melanocytes. Skin models have evolved from epidermis to complex models including a dermis. The purpose of the present study was to design a reconstructed full-thickness (FT) skin suitable to perform in vitro testing of both molecules and plant extracts. First, we reconstructed epidermis with normal human keratinocytes displaying the expected multilayered morphology and expressing specific epidermal proteins (e-cadherin, claudin-1, p63, Ki67, Keratin 10, filaggrin, and loricrin). Then, a dermal equivalent was developed using a collagen matrix allowing the growth of fibroblasts. The functionality of the dermis was demonstrated by the measurement of skin parameters such as rigidity or elasticity with Ballistometer ® and other parameters such as the contraction over time and the expression of dermal proteins. The combination of these two compartments (dermis and epidermis) allowed to reconstruct an FT model. This study model allowed to study the communication between compartments and with the establishment of a dermoepidermal junction showing the expression of specific proteins (collagen XVII, laminin, and collagen IV). Impact statement: The objective of our research project was to design a three-dimensional human full-thickness (FT) skin suitable to perform in vitro testing of molecules and plant ingredients. The combination of these two reconstructed compartments (dermis and epidermis) allowed to reconstruct an FT model. This study model allowed to study the communication between compartments and with the establishment of a dermoepidermal junction showing the expression of specific proteins (collagen XVII, laminin, and collagen IV). This in vitro model can be use by cosmetic and pharmaceutical industries to study the effect of chemical or natural compounds on the skin.
Traditional herbal medicine, ethnopharmacology, and evidence-based phytotherapy inspire the development of botanical active ingredients for cosmetics. Ensuring their authenticity and quality is essential in guaranteeing the safety and efficacy of cosmetic formulations. However, the industry faces challenges related to adulteration and inconsistent verification practices. Adulteration can occur at both the crude raw material stage and during processing, involving misidentification, contamination, or the addition of unauthorized substances. This review emphasizes the need for robust authentication methods, including botanical identification, genetic testing, and phytochemical/metabolomic profiling. Analytical tools such as UV/VIS spectroscopy, HPTLC, GC-MS, HPLC/UHPLC, and isotope analysis provide complementary data for detecting and addressing adulteration. Adulteration jeopardizes product safety, efficacy, regulatory compliance, and consumer trust, while dilutions or substitutions erode the intended health benefits. A standardized, comprehensive approach across the supply chain—from raw material sourcing to extract manufacturing—is critical for maintaining the integrity of botanical ingredients. Cosmetovigilance and nutrivigilance are crucial aspects of ensuring product safety and compliance. This review presents a novel perspective by highlighting that, while the pharmaceutical and nutraceutical industries have long recognized the risks of botanical adulteration, awareness in the cosmetics industry remains limited. It further integrates recent advancements in metabolomic profiling, global regulatory challenges, and the economic implications of botanical adulteration in cosmetics. Future developments in AI-driven authentication technologies may represent a promising solution for addressing evolving challenges in product safety and traceability.